Diabetic kidney disease: A call to primary care
Nephrologist and Endocrinologist Katherine Tuttle joins Primary Care Physician Jay Shubrook to discuss the importance of kidney disease screening for the prevention of downstream nephropathy and cardiovascular disease in patients with diabetes (8:16).
Learning points include:
- The importance of regular measurements of estimated glomerular filtration rate (eGFR; via blood) and albuminuria (via urine) tests to kidney and cardiovascular disease screening.
- An introduction to the Kidney Disease: Improving Global Outcomes (KDIGO) “heat map”, a useful prognostic tool for the risk stratification of patients with albuminuria and/or impaired glomerular filtration.
- Recommendations and common risk factors (eg, hypertension) for glycemic control and medication use in people with diabetes and kidney damage.
Part of the diabetes and kidney disease collection
- News story | Canagliflozin may offer renal protection in people with type 2 diabetes and CKD
- Video commentary | Lead investigator Vlado Perkovic talks about the main findings from the CREDENCE trial (6:51)
- Video commentary | John Wilding discusses how the CREDENCE trial findings may impact the treatment of people with type 2 diabetes and chronic kidney disease (3:31)